BioLineRx Ltd. (BLRX)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Total Assets (Quarterly) : 38.80M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 38.80M |
| December 31, 2025 | 40.90M |
| September 30, 2025 | 39.80M |
| June 30, 2025 | 43.27M |
| March 31, 2025 | 43.51M |
| December 31, 2024 | 38.91M |
| September 30, 2024 | 52.74M |
| June 30, 2024 | 64.60M |
| March 31, 2024 | 51.60M |
| December 31, 2023 | 63.92M |
| September 30, 2023 | 52.86M |
| June 30, 2023 | 58.94M |
| March 31, 2023 | 68.65M |
| December 31, 2022 | 76.38M |
| September 30, 2022 | 81.67M |
| June 30, 2022 | 67.84M |
| March 31, 2022 | 74.77M |
| December 31, 2021 | 81.39M |
| September 30, 2021 | 86.90M |
| June 30, 2021 | 91.33M |
| March 31, 2021 | 83.60M |
| December 31, 2020 | 47.29M |
| September 30, 2020 | 46.04M |
| June 30, 2020 | 52.99M |
| March 31, 2020 | 47.17M |
| Date | Value |
|---|---|
| December 31, 2019 | 53.57M |
| September 30, 2019 | 57.22M |
| June 30, 2019 | 61.96M |
| March 31, 2019 | 67.59M |
| December 31, 2018 | 56.23M |
| September 30, 2018 | 46.40M |
| June 30, 2018 | 52.21M |
| March 31, 2018 | 56.08M |
| December 31, 2017 | 60.96M |
| September 30, 2017 | 66.05M |
| June 30, 2017 | 62.99M |
| March 31, 2017 | 41.02M |
| December 31, 2016 | 38.90M |
| September 30, 2016 | 42.29M |
| June 30, 2016 | 45.68M |
| March 31, 2016 | 48.94M |
| December 31, 2015 | 51.30M |
| September 30, 2015 | 55.03M |
| June 30, 2015 | 58.36M |
| March 31, 2015 | 59.87M |
| December 31, 2014 | 36.19M |
| September 30, 2014 | 30.97M |
| June 30, 2014 | 35.08M |
| March 31, 2014 | 39.11M |
| December 31, 2013 | 20.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 383.16M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 16.03M |
| Revium Recovery, Inc. | 18.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.96M |
| Shareholders Equity (Quarterly) | 16.67M |
| Debt to Equity Ratio | 0.544 |
| Current Ratio | 1.584 |
| Net Debt Paydown Yield | 11.93% |